最新ニュース Axos Financial (NYSE:AX) 株価情報

Axos Financial

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment . The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

Axos Financial Inc

AXIOS SUSTANBLE GRWTH A by AXIOS Sustainable Growth Acquisition Corporation

AXIOS Sustainable Growth Acquisition Corp

AXA SA

Abraxas Petroleum Corp

AXIS BANK LTD S/GDR 144A by Axis Bank Ltd.

Axis Bank Ltd

AXIOS MOBILE ASSETS ORD by Axios Mobile Assets Corp.

EYES ON THE GO INC by Eyes on the Go, Inc.

Eyes on the Go Inc

ALLIXON INTL CORP by Allixon International Corp.

Allixon International Corp

AZUCAR MINERALS LTD by Azucar Minerals Ltd.

Azucar Minerals Ltd

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics Inc

AXEL

Axfood AB

AXIS ENERGY CORP by Axis Energy Corporation

Axis Energy Corp

Accent Group Ltd

Axogen Inc

ALEXIUM INTL GRP LTD ORD by Alexium International Group Ltd.

Alexium International Group Ltd

AXIL Brands Inc

AXIM BIOTECHNOLOGIES INC by Axim Biotechnologies, Inc.

AXIM Biotechnologies Inc

AXIS Token

American Axle & Manufacturing Holdings, Inc. Common Stock

American Axle & Mfg Holdings Inc

Axelar - United States Dollar

Axiologix Inc

AXMIN Inc

AXM PHARMA INC by AXM Pharma, Inc.

ALLIANCE NICKEL LTD by ALLIANCE NICKEL LTD

Alliance Nickel Ltd

AXION VENTURES INC by Axion Ventures Inc.

Axion Ventures Inc

AXONICS INC COM

Axon Enterprise Inc

American Express Co

AXPR

AXIS PETROLEUM CO CAP by Axis Petroleum Co.

AXION POWER INTL INC by Axion Power International, Inc.

Axion Power International Inc

Amrep Corp

AMARC RESOURCE LTD by Amarc Resources Ltd.

Amarc Resources Ltd

Amexdrug Corp

Axis Capital Holdings Limited Common Stock

Axis Capital Holdings Ltd

Axie Infinity - United States Dollar

Axsome Therapeutics Inc

Axis Capital Holdings Limited Depositary Shares, each representing 1/100th interest in a share of a 5.50% Series E Preferred Shares

Axalta Coating Systems Ltd. Common Shares

Axalta Coating Systems Ltd

AXIS TECHS GROUP INC by Axis Technologies Group, Inc.

Axis Technologies Group Inc

AXT Inc

AXTEL SAB DE CV B by Axtel S. A.. B. De CV

Axtel SAB de CV

CDN MAVERICK CAP CORP by CDN MAVERICK CAP CORP.

CDN Maverick Capital Corp

Exxe Group Inc

ALDERON IRON ORE CORP by Alderon Iron Ore Corp.

Alderon Iron Ore Corp

Axiata Group Bhd

<a href="https://www.theinformation.com/articles/palo-alto-networks-offers-smooth-ride-turbulent-markets" title="https://www.theinformation.com/articles/palo-alto-networks-offers-smooth-ride-turbulent-markets">https://www.theinformation.com/articles/palo-alto-networks-offers-smooth-ride-turbulent-markets</a>

News

PANW

'Palo Alto Networks Offers A Smooth Ride In Turbulent Markets' - The Information

RBC Capital analyst Karl Shepard maintains Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) with a Outperform and lowers the price target from $20 to $18.

Price Target

Analyst Ratings

HBAN

RBC Capital Maintains Outperform on Huntington Bancshares, Lowers Price Target to $18

<a href="https://www.ftc.gov/news-events/news/press-releases/2025/04/ftc-takes-action-against-uber-deceptive-billing-cancellation-practices" title="https://www.ftc.gov/news-events/news/press-releases/2025/04/ftc-takes-action-against-uber-deceptive-billing-cancellation-practices">https://www.ftc.gov/news-events/news/press-releases/2025/04/ftc-takes-action-against-uber-deceptive-billing-cancellation-practices</a>

Legal

UBER

'FTC Takes Action Against Uber For Deceptive Billing And Cancellation Practices; Says Company Enrolled Consumers In Subscription Service And Charged Them Without Their Consent, Made It Difficult For Users To Cancel'

JP Morgan analyst Jessica Fye maintains Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>) with a Neutral and raises the price target from $55 to $58.

HALO

JP Morgan Maintains Neutral on Halozyme Therapeutics, Raises Price Target to $58

RBC Capital analyst Karl Shepard maintains Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) with a Sector Perform and lowers the price target from $33 to $31.

HOMB

RBC Capital Maintains Sector Perform on Home BancShares, Lowers Price Target to $31

Editor&rsquo;s note: This article was originally published in June 2024. It has been updated as of April 2025 to reflect the latest developments in Marlon Wayans&rsquo; partnership with Dr. Green NFT.
&quot;When you get older, you do it with purpose,&quot; says <a href="https://elplanteo.com/marlon-wayans-cannabis-entrevista/">Marlon Wayans</a> in an exclusive interview, reflecting on his evolving relationship with <a href="https://www.benzinga.com/cannabis">cannabis</a>. The multi-talented actor, comedian, and producer, known for his iconic roles in weed-forward films like &quot;Scary Movie&quot; and &quot;Don&#39;t Be a Menace to South Central While Drinking Your Juice in the Hood,&quot; has seen his use of cannabis transition from youthful experimentation to a purposeful part of his lifestyle.
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" frameborder="0" height="315" src="https://www.youtube.com/embed/CK-rJrytmJE?si=vUOIW6C4IV_EpCn5&amp;start=17" width="560"></iframe>
He openly shares how his perspective has matured over the years. &quot;When you&#39;re younger, you just smoke because you like smoking; you want to get high and be with your friends,&quot; he explains. &quot;When you get older, it&#39;s like, okay, I&#39;m gonna do this strain because I want to just relax right now. I want this kind of weed because I just want to chill right now and have some fun.&quot; This evolution mirrors the broader societal shift towards understanding and embracing the multifaceted uses of cannabis, beyond mere recreation.
Also read:&nbsp;<a class="post-card-article-link" href="https://www.benzinga.com/markets/cannabis/25/04/39797136/tiffany-haddish-if-men-had-period-pain-weed-would-already-be-legal">Tiffany Haddish: &#39;If Men Had Period Pain, Weed Would Already Be Legal&#39;</a>
Calling from his home in Los Angeles, Wayans is in the midst of a busy schedule, juggling film shoots and stand-up shows. &quot;I&#39;ve been crazy. I was filming a movie&hellip; then wrapping the movie, then doing stand-up shows and promoting my special,&quot; he says. He recently finished filming a psychological horror movie directed by Justin Tipping and written by Jordan Peele, which is set to release in September 2025. &quot;I finally am home. I was in Albuquerque filming a Jordan Peele movie. I got the lead in this movie called &#39;Him&#39;&hellip; It got me in shape and I&#39;m happy about that because I play a football player. It&#39;s a great role, a great movie.&rdquo;
Despite his hectic life, Wayans makes time for projects that align with his passions, one of which is his partnership with <a href="https://drgreennft.com/platinum-holders/marlon-wayans" rel="nofollow noopener noreferrer" target="_blank">Dr. Green NFT</a>.
<h3>Business, Health, Relaxation, Creativity: One Plant Fits All</h3>
Wayans&#39; connection with Dr. Green NFT, spearheaded by British-Jamaican entrepreneur Maximillian White, marks his formal entry into the cannabis industry. His decision to join the project was carefully considered. &quot;I&#39;ve been offered a lot of deals. I was talking to a few people. I chose Dr. Green because I felt like this company actually knows what they&#39;re talking about,&quot; Wayans notes.
Today, Wayans holds a Platinum Digital Key within the Dr. Green ecosystem, granting him exclusive access to his own custom cannabis strain and distribution channel. &quot;What we&#39;re gonna do with the likes of Marlon is we&#39;re gonna ask him what he wants to see from his marijuana. We&#39;re gonna build him a specific strain set for him. Nobody else on the planet&#39;s gonna have that,&quot; White explains.
For Wayans, cannabis is not just about personal enjoyment; it&rsquo;s a tool for creativity and well-being. &quot;Sometimes it&#39;s just to relax, sometimes it&#39;s when I want to write,&quot; he shares. &quot;I want to think creatively and allow my mind to expand, so I smoke a specific strain or take a specific gummy.&quot;
Wayans&#39; advocacy extends beyond personal use as he addresses systemic issues. He is acutely aware of the racial biases that have marred the history of cannabis legislation and enforcement in the United States. &quot;A lot of my friends used to get pulled over and get in trouble for smoking weed,&quot; he recalls, pointing out the&nbsp;<a href="https://www.aclu.org/publications/report-war-marijuana-black-and-white" rel="nofollow noopener noreferrer" target="_blank">disproportionate impact on Black and Brown communities</a>. While acknowledging the progress made, he insists there&#39;s still a long way to go in ensuring equitable treatment and opportunities within the industry.
Additionally, he is a strong proponent of the plant&rsquo;s therapeutic value. &quot;I have two friends battling cancer right now and when they&#39;re in severe pain, exactly what they do is get them some cannabis, and it&#39;s the only thing that stops the pain,&quot; he says.
Reflecting on his career, Wayans discusses how cannabis has influenced his work: &quot;For me, I always like the movies I make, and it&#39;s funny. It&#39;s not on purpose, but we made movies for weedheads. If you look at &#39;Scary Movie,&#39; Shorty, the character, was literally every dude I knew in the 90s wrapped up in one.&quot;
&quot;My message is always gonna be life, love, and laughter, no matter what I do. Over the years, I&rsquo;ve fed a lot of laughs to my audience. So when it comes to me and marijuana, I&#39;m bringing the fun, the laughs, the jokes, the silly, the creative&hellip; all the good things that I extracted from the culture. I&#39;m giving back to the culture and looking forward to making more movies, smoking and having my marijuana, and making myself loud, smoking my own marijuana tomorrow.&quot;
His involvement with Dr. Green NFT has also provided an educational opportunity. In 2024, Wayans toured the company&rsquo;s cultivation and research facilities in Portugal, where he learned firsthand about cannabis genetics, seed-to-sale traceability, and blockchain integration. &quot;This is school. I&#39;m going to weed school,&quot; he said at the time.
<h3>Dr. Green NFT: Where Blockchain Meets Cannabis</h3>
Dr. Green NFT integrates blockchain technology with cannabis cultivation and distribution, addressing product authenticity and access. The company&rsquo;s Digital Keys act as virtual licenses, allowing holders to participate in cannabis distribution without owning a physical business. Entry-level keys start around $10,000 and provide access to Dr. Green&rsquo;s infrastructure &mdash; from licensing and compliance to packaging and logistics.
Unlike traditional models, Dr. Green NFT avoids retail storefronts. Instead, NFT holders function as wholesale partners. &quot;We don&#39;t want speculative holders. We&#39;re not an investment product,&quot; CTO Ricardo Capone explains. &quot;We want them to buy [the NFT] and use it to transact cannabis.&quot;
One of the company&rsquo;s most innovative features is bespoke medicine. Through DNA analysis, Dr. Green&rsquo;s research labs in Portugal create personalized cannabis treatments for conditions like epilepsy or Parkinson&rsquo;s. &quot;We analyze saliva samples and tailor the cannabinoids and terpenes accordingly,&quot; says Capone.
The European cannabis market is expected to surpass &euro;123 billion by 2028, according to&nbsp;<a href="https://prohibitionpartners.com/reports/the-european-cannabis-report-4th-edition/" rel="nofollow noopener noreferrer" target="_blank">Prohibition Partners</a>. Dr. Green NFT positions itself at the intersection of that growth, combining transparency, tech and access &mdash; and figures like Wayans help amplify the mission globally.
<h3>&lsquo;Cannabis Criminalization Was Always A Tool&rsquo;</h3>
Wayans&rsquo; commitment to Dr. Green NFT is not just about business; it reflects a deeper belief in social justice. &quot;The criminalization of cannabis&hellip; it&rsquo;s always an excuse for Black and Browns to be arrested and to be messed with by cops,&quot; he asserts. By lending his name and platform to an equity-minded cannabis tech company, Wayans hopes to help democratize access and education around the plant.
Maximillian White, Dr. Green&rsquo;s founder, shares that vision. &quot;My retirement now over the next few years is giving back to marijuana what I took from marijuana and making sure that we&#39;ve got a revolution,&quot; he says. &quot;We&#39;re gonna legalize this and make sure that every European country allows people to buy it legally. It&#39;s controlled; they can use their money for tax purposes.&quot;
With a focus on transparency, technology, and community, the partnership between Wayans and Dr. Green NFT represents a new blueprint for how celebrities can influence &mdash; and shape &mdash; the cannabis space for the better.
Disclosure: The content of this article is for informational purposes only and should not be considered investment advice. Please consult a licensed professional before making financial decisions.
Follow me on&nbsp;<a href="https://www.twitter.com/javierhasse" rel="nofollow noopener noreferrer" target="_blank">Twitter</a>&nbsp;or&nbsp;<a href="https://www.linkedin.com/in/javierhasse/" rel="nofollow noopener noreferrer" target="_blank">LinkedIn</a>.&nbsp;Check out&nbsp;my&nbsp;<a href="https://elplanteo.com/" rel="nofollow noopener noreferrer" target="_blank">website</a>&nbsp;or&nbsp;some of my other work&nbsp;<a href="https://benzinga.com/cannabis" rel="nofollow noopener noreferrer" target="_blank">here</a>.&nbsp;
This article was originally published on <a href="https://www.forbes.com/sites/javierhasse/2024/06/07/marlon-wayans-tackles-hard-hitting-questions-as-he-joins-cannabis-mogul-in-new-venture-all-about-giving-back-to-the-culture/">Forbes</a> and appears here with permission.&nbsp;The article is from an external source. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.
Photo: Shutterstock

Cannabis

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Entertainment

Markets

Tech

Interview

General

Marlon Wayans Talks Selling Weed On The Blockchain: Is Dr. Green Legit? He Isn't Afraid To Answer The Tough Questions

<h3>Gainers</h3>
<ul>
<li>SHF Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>) shares increased by 72.2% to $3.84 during Monday's regular session. The market value of their outstanding shares is at $10.6 million. </li>
<li>Forge Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRGE#NYSE">FRGE</a>) shares moved upwards by 38.6% to $12.04. The company's market cap stands at $151.0 million. </li>
<li>Ohio Valley Banc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVBC#NASDAQ">OVBC</a>) shares rose 12.78% to $40.04. The market value of their outstanding shares is at $188.6 million. </li>
<li>Innventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) stock moved upwards by 12.57% to $3.57. The market value of their outstanding shares is at $168.0 million. </li>
<li>MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNGD#NYSE">FNGD</a>) shares increased by 10.57% to $18.34. </li>
<li>Waton Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTF#NASDAQ">WTF</a>) shares moved upwards by 10.33% to $7.15. The market value of their outstanding shares is at $344.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CaliberCos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWD#NASDAQ">CWD</a>) shares fell 23.9% to $0.23 during Monday's regular session. The market value of their outstanding shares is at $5.1 million. </li>
<li>Sezzle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) shares declined by 14.31% to $38.39. The company's market cap stands at $1.2 billion. </li>
<li>AGM Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>) stock declined by 13.9% to $0.03. The market value of their outstanding shares is at $1.0 million. </li>
<li>Beneficient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BENF#NASDAQ">BENF</a>) stock declined by 13.69% to $0.23. The company's market cap stands at $2.0 million. </li>
<li>Janover (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JNVR#NASDAQ">JNVR</a>) shares decreased by 13.01% to $46.0. The market value of their outstanding shares is at $65.7 million. </li>
<li>Webull (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) shares fell 12.93% to $22.93. The company's market cap stands at $10.5 billion. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AGMH

BENF

BULL

FNGD

FRGE

JNVR

OVBC

SEZL

SHF Holdings, Inc. - Class A Common Stock

SHFS

12 Financials Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Mingteng International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEN#NASDAQ">MTEN</a>) stock increased by 36.4% to $5.75 during Monday's regular session. The company's market cap stands at $39.3 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) stock increased by 21.36% to $0.94. </li>
<li>Damon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMN#NASDAQ">DMN</a>) stock moved upwards by 19.11% to $0.0. The market value of their outstanding shares is at $3.1 million. </li>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) shares moved upwards by 16.91% to $0.36. The company's market cap stands at $2.0 million. </li>
<li>YSX Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YSXT#NASDAQ">YSXT</a>) shares rose 10.28% to $5.04. The market value of their outstanding shares is at $118.1 million. </li>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) shares rose 9.86% to $0.87. The market value of their outstanding shares is at $6.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) shares declined by 64.4% to $2.44 during Monday's regular session. The company's market cap stands at $2.8 million. </li>
<li>Thunder Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) shares decreased by 62.95% to $0.05. The market value of their outstanding shares is at $2.5 million. </li>
<li>ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>) shares decreased by 22.58% to $0.38. The market value of their outstanding shares is at $13.3 million. As per the news, the Q4 earnings report came out 4 days ago. </li>
<li>Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) shares decreased by 22.12% to $0.1. The company's market cap stands at $5.9 million. </li>
<li>Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) shares decreased by 21.33% to $0.09. The company's market cap stands at $4.5 million. </li>
<li>Lazydays Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) stock declined by 21.22% to $0.2. The company's market cap stands at $22.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIEV

ECDA

EZGO

GORV

LXEH

MTEN

YSXT

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Intelligent Protection (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPM#NASDAQ">IPM</a>) shares rose 20.0% to $1.98 during Monday's regular session. The market value of their outstanding shares is at $18.2 million. </li>
<li>WiMi Hologram Cloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIMI#NASDAQ">WIMI</a>) shares rose 18.57% to $4.98. The market value of their outstanding shares is at $48.9 million. </li>
<li>AirNet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANTE#NASDAQ">ANTE</a>) shares rose 17.16% to $0.86. The market value of their outstanding shares is at $12.2 million. </li>
<li>Global Mofy AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) stock moved upwards by 14.11% to $1.94. The company's market cap stands at $5.6 million. </li>
<li>Baosheng Media Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) shares moved upwards by 10.0% to $1.87. The company's market cap stands at $2.8 million. </li>
<li>Blue Hat Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>) shares moved upwards by 9.6% to $2.6. The market value of their outstanding shares is at $12.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>iOThree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOTR#NASDAQ">IOTR</a>) stock declined by 27.6% to $0.83 during Monday's regular session. The market value of their outstanding shares is at $21.3 million. </li>
<li>Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) stock decreased by 25.09% to $2.12. The market value of their outstanding shares is at $3.4 million. </li>
<li>Motorsport Games (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) stock decreased by 21.46% to $2.16. The market value of their outstanding shares is at $6.8 million. </li>
<li>Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) shares declined by 15.72% to $0.54. The company's market cap stands at $10.2 million. </li>
<li>AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) stock decreased by 13.09% to $20.33. The market value of their outstanding shares is at $4.0 billion. </li>
<li>Newsmax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMAX#NYSE">NMAX</a>) shares decreased by 12.82% to $22.23. The company's market cap stands at $2.8 billion. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANTE

ASTS

BAOS

BHAT

DRCT

IOTR

MSGM

NMAX

WIMI

12 Communication Services Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) shares increased by 41.1% to $0.44 during Monday's regular session. The market value of their outstanding shares is at $4.9 million. </li>
<li>Dogwood Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) shares moved upwards by 37.47% to $5.87. The market value of their outstanding shares is at $11.2 million. </li>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) shares moved upwards by 35.73% to $1.17. The company's market cap stands at $3.7 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares increased by 27.36% to $10.75. The company's market cap stands at $67.9 million. </li>
<li>Annovis Bio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NYSE">ANVS</a>) shares increased by 24.99% to $1.52. The company's market cap stands at $29.7 million. </li>
<li>Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) stock rose 24.72% to $3.43. The market value of their outstanding shares is at $207.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) stock declined by 48.5% to $0.07 during Monday's regular session. </li>
<li>Vincerx Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINC#NASDAQ">VINC</a>) shares decreased by 42.91% to $0.16. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock declined by 36.12% to $1.38. The company's market cap stands at $18.9 million. </li>
<li>Adagio Medical Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADGM#NASDAQ">ADGM</a>) stock fell 29.77% to $1.25. The company's market cap stands at $19.3 million. </li>
<li>Channel Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) stock declined by 23.92% to $1.4. The market value of their outstanding shares is at $8.4 million. </li>
<li>Zhengye Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYBT#NASDAQ">ZYBT</a>) shares decreased by 23.07% to $7.74. The company's market cap stands at $366.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADGM

ANVS

APVO

CHRO

DWTX

RSLS

RZLT

SCPX

SXTC

VINC

XCUR

ZYBT

12 Health Care Stocks Moving In Monday's Intraday Session

RBC Capital analyst Mike Dahl maintains D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) with a Underperform and lowers the price target from $125 to $105.

RBC Capital Maintains Underperform on D.R. Horton, Lowers Price Target to $105

ATLANTA, April 21, 2025 /PRNewswire/ -- Southern Company today announced it is increasing its dividend by 8 cents per share on an annualized basis to a rate of $2.96 per share.
This marks the 77th consecutive year that Southern Company has paid a dividend on its common stock that is equal to or greater than the previous quarter. Additionally, this is the 24th consecutive year the company has raised its dividend.
Southern Company also announced a regular quarterly dividend – including an increase of 2 cents per share over the prior quarter – of 74 cents per share, payable June 6, 2025 to shareholders of record as of May 19, 2025. &nbsp;

Dividends

Southern Raises Quarterly Dividend From $0.72/Shr To $0.74/Shr

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 1,000 points on Monday.
The Dow traded down 2.73% to 38,072.59 while the NASDAQ fell 3.19% to 15,767.59. The S&amp;P 500 also fell, dropping, 2.86% to 5,131.53.
Check This Out: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44895495/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-delivering-high-dividend-yields-5">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Consumer staples shares fell by just 0.7% on Monday.
In trading on Monday, consumer discretionary shares tumbled by 3.1%.
Top Headline
Comerica Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) reported better-than-expected earnings for its first quarter on Monday.
The company posted quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $1.15 per share. The company reported quarterly sales of $829.00 million which missed the analyst consensus estimate of $831.34 million.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Upexi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) shares shot up 619% to $16.31 after the company announced a private placement with approximately $100 million in gross proceeds.</li>
<li>Shares of SHF Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>)got a boost, surging 93% to $4.12 after gaining 18% on Thursday. SHF Holdings announced a strategic partnership with FundCanna to expand access to capital for cannabis operators.</li>
<li>Wolverine World Wide, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WWW#NYSE">WWW</a>) shares were also up, gaining 8% to $11.62. Baird analyst Jonathan Komp upgraded the rating for Wolverine World Wide from Neutral to Outperform.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Thunder Power Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) shares dropped 63% to $0.0506 after the company received delisting notice from the Nasdaq.</li>
<li>Shares of New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) were down 12% to $5.03 after the company announced a $700 million proposed offering of senior notes.</li>
<li>TechTarget, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTGT#NASDAQ">TTGT</a>) was down, falling 11% to $7.26. Informa TechTarget announced the receipt of Nasdaq notification of non-compliance regarding delayed 2024 Form 10-K filing.</li>
</ul>
Commodities In commodity news, oil traded down 2.6% to $62.97 while gold traded up 3.3% at $3,439.00.
Silver traded up 1.2% to $32.850 on Monday, while copper rose 1% to $4.7835.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.29%, Germany's DAX 40 declined 0.64% and France's CAC 40 dipped 0.76%. Spain's IBEX 35 Index slipped 0.2%, while London's FTSE 100 fell 0.18%.
Asia Pacific Markets
Asian markets closed mixed on Monday, with Japan's Nikkei 225 falling 1.30%, China's Shanghai Composite gaining 0.45% and India's BSE Sensex gaining 1.09%.
Economics
No major economic data is scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44896269/how-to-earn-500-a-month-from-3m-stock-ahead-of-q1-earnings">How To Earn $500 A Month From 3M Stock Ahead Of Q1 Earnings</a> </li>
</ul>
Photo via Shutterstock

Earnings

Equities

Eurozone

Commodities

Intraday Update

Trading Ideas

TTGT

UPXI

Dow Dips Over 1,000 Points; Comerica Earnings Top Views

B of A Securities analyst Curtis Nagle maintains Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) with a Neutral and lowers the price target from $36 to $33.

MTCH

B of A Securities Maintains Neutral on Match Group, Lowers Price Target to $33

Mercantile Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBWM#NASDAQ">MBWM</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Mercantile Bank will report an earnings per share (EPS) of $1.05.
Investors in Mercantile Bank are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company beat EPS by $0.08, leading to a 3.76% increase in the share price the following trading session.
Here's a look at Mercantile Bank's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.14</td>
<td>1.17</td>
<td>1.15</td>
<td>1.14</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.22</td>
<td>1.22</td>
<td>1.17</td>
<td>1.34</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.0%</td>
<td>4.0%</td>
<td>0.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745254934_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Mercantile Bank were trading at $40.68 as of April 18. Over the last 52-week period, shares are up 8.61%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MBWM/earnings">To track all earnings releases for Mercantile Bank visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MBWM

Earnings Preview: Mercantile Bank

East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.
Analysts are estimating that East West Bancorp will report an earnings per share (EPS) of $2.06.
Investors in East West Bancorp are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings Track Record</h3>
The company's EPS missed by $0.04 in the last quarter, leading to a 0.55% drop in the share price on the following day.
Here's a look at East West Bancorp's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.12</td>
<td>2.06</td>
<td>1.97</td>
<td>2</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.08</td>
<td>2.09</td>
<td>2.07</td>
<td>2.08</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>6.0%</td>
<td>1.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745254925_0.png" alt="eps graph" />
<h3>Market Performance of East West Bancorp's Stock</h3>
Shares of East West Bancorp were trading at $77.43 as of April 18. Over the last 52-week period, shares are up 0.52%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/EWBC/earnings">To track all earnings releases for East West Bancorp visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EWBC

What's Next: East West Bancorp's Earnings Preview

United Community Banks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UCB#NYSE">UCB</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.
Analysts estimate that United Community Banks will report an earnings per share (EPS) of $0.56. 
The market awaits United Community Banks's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.07, leading to a 0.0% drop in the share price on the subsequent day.
Here's a look at United Community Banks's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.56</td>
<td>0.57</td>
<td>0.51</td>
<td>0.49</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.63</td>
<td>0.57</td>
<td>0.58</td>
<td>0.52</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>0.0%</td>
<td>4.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745254915_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of United Community Banks were trading at $24.79 as of April 18. Over the last 52-week period, shares are down 6.88%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/UCB/earnings">To track all earnings releases for United Community Banks visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: United Community Banks's Earnings Preview

Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-22. Here's what investors need to know before the announcement.
Analysts estimate that Renasant will report an earnings per share (EPS) of $0.61. 
Anticipation surrounds Renasant's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
Last quarter the company beat EPS by $0.12, which was followed by a 1.07% increase in the share price the next day.
Here's a look at Renasant's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.61</td>
<td>0.63</td>
<td>0.66</td>
<td>0.62</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.73</td>
<td>0.70</td>
<td>0.69</td>
<td>0.65</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>5.0%</td>
<td>-2.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745254907_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Renasant were trading at $28.18 as of April 18. Over the last 52-week period, shares are down 8.65%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/RNST/earnings">To track all earnings releases for Renasant visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RNST

Exploring Renasant's Earnings Expectations

Invesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Invesco will report an earnings per share (EPS) of $0.38.
Investors in Invesco are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
Last quarter the company beat EPS by $0.05, which was followed by a 1.76% drop in the share price the next day.
Here's a look at Invesco's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.47</td>
<td>0.43</td>
<td>0.40</td>
<td>0.40</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.52</td>
<td>0.44</td>
<td>0.43</td>
<td>0.33</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-3.0%</td>
<td>-1.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745254897_0.png" alt="eps graph" />
<h3>Performance of Invesco Shares</h3>
Shares of Invesco were trading at $12.8 as of April 18. Over the last 52-week period, shares are down 14.57%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analysts' Perspectives on Invesco</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Invesco.
Analysts have given Invesco a total of 19 ratings, with the consensus rating being Neutral. The average one-year price target is $17.51, indicating a potential 36.8% upside.
<h3>Comparing Ratings with Competitors</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Hamilton Lane, Janus Henderson Group and Affiliated Managers Group, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Hamilton Lane, with an average 1-year price target of $158.6, suggesting a potential 1139.06% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Janus Henderson Group, with an average 1-year price target of $43.38, suggesting a potential 238.91% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Affiliated Managers Group, with an average 1-year price target of $194.5, suggesting a potential 1419.53% upside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
Within the peer analysis summary, vital metrics for Hamilton Lane, Janus Henderson Group and Affiliated Managers Group are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Invesco</td>
<td>Neutral</td>
<td>12.71%</td>
<td>$602.60M</td>
<td>1.97%</td>
</tr>
<tr>
<td>Hamilton Lane</td>
<td>Neutral</td>
<td>34.33%</td>
<td>$128.63M</td>
<td>8.44%</td>
</tr>
<tr>
<td>Janus Henderson Group</td>
<td>Neutral</td>
<td>24.59%</td>
<td>$485.80M</td>
<td>2.79%</td>
</tr>
<tr>
<td>Affiliated Managers Group</td>
<td>Neutral</td>
<td>4.32%</td>
<td>$285.50M</td>
<td>4.87%</td>
</tr>
</tbody>
</table>

Key Takeaway:
In terms of revenue growth, Invesco is at the bottom among its peers. Invesco also ranks lowest in gross profit. However, Invesco is in the middle for return on equity.
<h3>Discovering Invesco: A Closer Look</h3>
Invesco provides investment-management services to retail (68% of managed assets) and institutional (32%) clients. At the end of October 2024, the firm had $1.792 trillion in assets under management spread among its equity (58% of AUM), balanced (3%), fixed-income (22%), alternative investment (7%), and money market (10%) operations. Passive products account for 43% of Invesco's total AUM, including 65% of the company's equity operations and 15% of its fixed-income platform. Invesco's us retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 29% of its AUM sourced from Europe, Africa, and the Middle East (14%) and Asia (15%).
<h3>A Deep Dive into Invesco's Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Invesco showcased positive performance, achieving a revenue growth rate of 12.71% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Invesco's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 13.14%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Invesco's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.97%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Invesco's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.77%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Invesco's debt-to-equity ratio is below the industry average at 0.72, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/IVZ/earnings">To track all earnings releases for Invesco visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Invesco's Earnings

Iridium Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-04-22. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Iridium Comms will report an earnings per share (EPS) of $0.28.
Iridium Comms bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings Track Record</h3>
In the previous earnings release, the company beat EPS by $0.10, leading to a 1.13% drop in the share price the following trading session.
Here's a look at Iridium Comms's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.22</td>
<td>0.20</td>
<td>0.17</td>
<td>0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.32</td>
<td>0.21</td>
<td>0.27</td>
<td>0.16</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>-6.0%</td>
<td>-5.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745254889_0.png" alt="eps graph" />
<h3>Tracking Iridium Comms's Stock Performance</h3>
Shares of Iridium Comms were trading at $23.77 as of April 18. Over the last 52-week period, shares are down 19.33%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analyst Views on Iridium Comms</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Iridium Comms.
Analysts have given Iridium Comms a total of 1 ratings, with the consensus rating being Outperform. The average one-year price target is $38.0, indicating a potential 59.87% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Globalstar and Lumen Technologies, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Globalstar, with an average 1-year price target of $43.33, suggesting a potential 82.29% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Lumen Technologies, with an average 1-year price target of $5.25, suggesting a potential 77.91% downside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
The peer analysis summary presents essential metrics for Globalstar and Lumen Technologies, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Iridium Comms</td>
<td>Outperform</td>
<td>9.37%</td>
<td>$152.78M</td>
<td>5.86%</td>
</tr>
<tr>
<td>Globalstar</td>
<td>Buy</td>
<td>16.73%</td>
<td>$39.20M</td>
<td>-14.05%</td>
</tr>
<tr>
<td>Lumen Technologies</td>
<td>Neutral</td>
<td>-5.35%</td>
<td>$1.62B</td>
<td>21.09%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Iridium Comms ranks highest in revenue growth among its peers. It also leads in gross profit margin. However, it has the lowest return on equity compared to its peers.
<h3>About Iridium Comms</h3>
Iridium Communications Inc is the commercial provider of communications services offering true globalised coverage, connecting people, organizations and assets to and from anywhere, in real time. The company is a provider of mobile voice and data communications services through a constellation of low earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies world-wide. The Company operates in one business segment, providing satellite communications services and products.
<h3>Understanding the Numbers: Iridium Comms's Finances</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Iridium Comms displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 9.37%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Communication Services sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Iridium Comms's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 17.06%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 5.86%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Iridium Comms's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.34%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 3.11, Iridium Comms adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/IRDM/earnings">To track all earnings releases for Iridium Comms visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Axos Financial

ニュース

最新ニュース Axos Financial (NYSE:AX) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル